Citadel Advisors’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Buy
+52,000
New +$315K ﹤0.01% 10952
2025
Q3
Sell
-30,100
Closed -$394K 13523
2025
Q2
$394K Buy
30,100
+14,300
+91% +$185K ﹤0.01% 9182
2025
Q1
$230K Buy
15,800
+10,800
+216% +$204K ﹤0.01% 10169
2024
Q4
$87.7K Buy
5,000
+4,700
+1,567% +$65.9K ﹤0.01% 11660
2024
Q3
$3.62K Buy
+300
New +$2.48K ﹤0.01% 13641
2024
Q1
Sell
-300
Closed -$1.8K 15089
2023
Q4
$1.8K Buy
+300
New +$1.98K ﹤0.01% 13774

Other funds holding LFVN

Citadel Advisors's LFVN Position: Q2 2026 in Review

Citadel Advisors increased its LifeVantage (LFVN) stake by 30% in Q2 2026, buying an estimated $141K and bringing the position to 99,791 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #9345.

Citadel Advisors first reported a position in LFVN in Q3 2013 and has held it in 24 quarters since. The position peaked at $897K in Q1 2014. 89 funds tracked by Wall St. Rank hold LFVN as of Q2 2026.

  • Citadel Advisors held 99,791 shares of LifeVantage worth $623K as of Q2 2026.
  • Citadel Advisors bought 23,281 LifeVantage shares in Q2 2026, an estimated $141K.
  • LifeVantage made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9345 holding.
  • Citadel Advisors first reported a position in LifeVantage in Q3 2013 and has held it in 24 quarters since.
  • Citadel Advisors's LifeVantage position peaked at $897K in Q1 2014.
  • 89 funds tracked by Wall St. Rank held LifeVantage as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.